Cargando…
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326273/ https://www.ncbi.nlm.nih.gov/pubmed/34349509 http://dx.doi.org/10.2147/IJN.S330286 |
Ejemplares similares
-
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives
por: Edis, Zehra, et al.
Publicado: (2021) -
Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature [Corrigendum]
Publicado: (2022) -
Corrigendum to “Drug Delivery Nanoparticles in Skin Cancers”
por: Dianzani, Chiara, et al.
Publicado: (2021) -
Intrathecal Drug Delivery Systems Survey: Trends in Utilization in Pain Practice [Corrigendum]
Publicado: (2023) -
Nanocarriers for anticancer drugs: Challenges and perspectives
por: Alqosaibi, Amany I.
Publicado: (2022)